News Details

( 31 Oct 2020)
Sun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release relating to 5-year sustained efficacy and safety results for ILUMYAr in patients with moderate-to-severe plaque psoriasis, which we shall be releasing after sending this letter to you. This is for your information and record.

Thanking you,